US Stock MarketDetailed Quotes

MXCT MaxCyte

Watchlist
  • 4.170
  • +0.100+2.46%
Close Feb 14 16:00 ET
439.86MMarket Cap-12.26P/E (TTM)

MaxCyte Key Stats

MaxCyte Q4 2024 Estimates Date

Currency:USDMar 11, 2025

Estimate YoY
Revenue
7.98M
-49.08%
EPS
-0.12
-144.29%
Strong Buy

Feb 11, 2025

MaxCyte Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 9.519M--
Mar 11, 20252024/Q4-- / 7.978M--
Nov 6, 20242024/Q38.164M / 7.364M--
Aug 6, 20242024/Q210.429M / 7.933M--
May 7, 20242024/Q111.342M / 7.441M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 9.519M--
Mar 11, 20252024/Q4-- / 7.978M--
Nov 6, 20242024/Q38.164M / 7.364M--
Aug 6, 20242024/Q210.429M / 7.933M--
May 7, 20242024/Q111.342M / 7.441M--

Unlock Free Earnings Estimates

MaxCyte Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 11, 2025

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data